2m 2m 2m 2m 2m 2m 2m
- $2.3MMarket Cap
- -35.29%1-Year Change
- Medical DevicesIndustry
Vycor Medical (VYCO)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 41
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreInformation as of 05/28/2026
Company Profile
Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. The company operates through two segments: Vycor Medical and NovaVision. Its Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation therapies targeted at people who have impaired vision as a result of stroke or other brain injury. It has a license agreement with a German-based partner. It primarily serves hospitals and medical professionals. The company was incorporated in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. operates as a subsidiary of Fountainhead Capital Management Ltd.
Key Executives
- David Marc Cantor
- Adrian Christopher Liddell
- Peter C. Zachariou
Current Ownership Distribution
- Insiders22.1M (66.13%)
- Other11.3M (33.87%)
- Institutions0 (0.00%)
- Mutual Funds0 (0.00%)